Showing results (2111-2120 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 14, 2014
The co-agonist site of NMDA-glutamate receptors: a novel therapeutic target for age-related cognitive declineRogerio Panizzutti, Linda Scoriels, Marcos AvellarCurrent Pharmaceutical Design|January 14, 2014
Predicting protein-ligand interactions based on chemical preference features with its application to new D-amino acid oxidase inhibitor discoveryMingzhu Zhao, Hao-Teng Chang, Qiang Zhou, et al.Current Pharmaceutical Design|July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promisingFrancesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.Current Pharmaceutical Design|June 6, 2014
Anti-HER2 cancer therapy and cardiotoxicityTania Babar, Christopher Blomberg, Eileen Hoffner, et al.Current Pharmaceutical Design|January 24, 2015
Anticancer Advances of Matrine and Its DerivativesJianping Yong, Xiaoyuan Wu, Canzhong LuCurrent Pharmaceutical Design|September 7, 2012
Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitorsRui Wang, Linjie Guo, Pu Wang, et al.Current Pharmaceutical Design|September 7, 2012
Gastric mucosal protection and central nervous systemKlara Gyires, Jozsef Németh, Zoltan S ZádoriCurrent Pharmaceutical Design|September 7, 2012
Novel pharmacologic approaches to the prevention and treatment of ulcerative colitisXiaoming Deng, Sandor Szabo, Tetyana Khomenko, et al.Current Pharmaceutical Design|September 7, 2012
Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypesAndreas Stengel, Jean Rivier, Yvette TachéCurrent Pharmaceutical Design|September 29, 2012
Phosphonic esters and their application of protease controlRenata Grzywa, Marcin SieńczykPageof 1,008